Improved deal means new treatment for a type of advanced breast cancer can be recommended by NICE

Draft guidance published today (22 May 2020) by NICE recommends atezolizumab for treating people with a type of breast cancer, called triple negative breast cancer, that has spread to other parts of the body.

Read news story



NICE Annual Conference 2020

NICE 2020: Connecting evidence, people and practice will showcase the latest developments in clinical improvement, health technologies and patient-centred care. The event will outline the innovations shaping health and care, together with practical advice for those on the frontline of delivering high quality care.

The event takes place on Wednesday 11 November 2020 at the Hilton Manchester Deansgate.

Press and media

Contact the press office: 0300 323 0142 |